TROSPIUM CHLORIDE (Apotex Corp.)
Welcome to the PulseAid listing for the TROSPIUM CHLORIDE drug offered from Apotex Corp.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | TROSPIUM CHLORIDE |
SUBSTANCE NAME: | TROSPIUM CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-10-15 |
END MARKETING DATE: | 0000-00-00 |
TROSPIUM CHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | TROSPIUM CHLORIDE from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2012-10-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-3454_5c843d83-0799-3bb8-662e-01f186b1d230 |
PRODUCT NDC: | 60505-3454 |
APPLICATION NUMBER: | ANDA091513 |
Other TROSPIUM CHLORIDE Pharmaceutical Manufacturers / Labelers: